Developing New Version of OmniPod Insulin Pump

[Northerner]

Insulet Corp., the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, entered into an agreement with Eli Lilly and Company. The agreement will have Insulet develop a new version of the medical device for which they are known, the OmniPod insulin pump, only this one will be specifically designed to deliver Humulin R U-500 insulin, (regular U-500 [Concentrated] insulin human injection, USP [rDNA origin]), a concentrated form of insulin used by people with highly insulin resistant type 2 diabetes. Insulet is partnering with Eli Lilly and Company on the clinical development program to evaluate the safety and efficacy of the combined delivery system.

http://www.onlinetmd.com/medical-device-omnipod-insulin-pump-050713.aspx